Pursuant to Streamlined Sales Tax Governing Board Rule 902, this message shall serve as official notice of the commencement of the 10-day public comment period for the Interpretation Request received from Mr. Lawrence Shay and Mr. John Rielly of Haemonetics. The request is seeking a determination as to whether certain products qualify as suture alternatives. Specifically, the request is asking whether the Vascade® vascular closure system qualifies as a suture alternative. Staples, Sutures and Suture Alternatives are listed as “Prosthetic Devices” in Appendix L of the Streamlined Sales Tax Governing Board’s Rules and Procedures.
The Interpretation Request and Supplemental Information provides may be viewed at the following links: Interpretation Request – Suture Alternative – Vascular Closure Device (RI24001) and Vascade Closure Device Background (RI24002).
On November 21, 2024, the Compliance Review and Interpretations Committee (CRIC) voted to accept the Interpretation Request and develop an interpretive opinion on the question being asked.
The Compliance Review and Interpretations Committee may hold a hearing on this request any time after this 10-day public comment period, which ends on December 2, 2024. An official notice will be sent at least 10-days prior to that meeting.
Please email any public comments on this interpretation request to craig.johnson@sstgb.org, no later than December 2, 2024. Any public comments received will be posted to the Streamlined Sales Tax Governing Board’s website.
If you have any questions concerning this, please feel free to contact me.
Craig Johnson
Executive Director
Streamlined Sales Tax® Governing Board, Inc.